Evidence map›Paper›PMID 35234449›Full record

ArticleAnalytical chemistry2022

Ultrahigh-Throughput Sample Analysis Using Liquid Atmospheric Pressure Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry.

Henriette Krenkel, Jeffery Brown, Keith Richardson, Emmy Hoyes, Michael Morris, Rainer Cramer

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Ultra-High-Throughput and Low-Volume Analysis of Intact Proteins with LAP-MALDI MS.Journal of the American Society for Mass Spectrometry · 2023
    Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Henriette KrenkelDepartment of Chemistry, University of Reading, Whiteknights, Reading RG6 6DX, U.K.
Jeffery BrownWaters Corporation, Stamford Avenue, Wilmslow SK9 4AX, U.K.ORCID 0000-0001-8569-7174
Keith RichardsonWaters Corporation, Stamford Avenue, Wilmslow SK9 4AX, U.K.ORCID 0000-0001-5224-0688
Emmy HoyesWaters Corporation, Stamford Avenue, Wilmslow SK9 4AX, U.K.
Michael MorrisWaters Corporation, Stamford Avenue, Wilmslow SK9 4AX, U.K.
Rainer CramerDepartment of Chemistry, University of Reading, Whiteknights, Reading RG6 6DX, U.K.ORCID 0000-0002-8037-2511
Waters (United States) · USUniversity of Reading · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mass spectrometry (MS) allows for automated analysis of complex samples at high resolution without the need for labeling/derivatization. Liquid atmospheric pressure matrix-assisted laser desorption/ionization (LAP-MALDI) enables rapid sample preparation and MS analysis using microtiter-plate formats and high-performing mass spectrometers. We present a step change in high-speed, large-scale MS sample analysis of peptides at 20 samples/s and an enzymatic assay at 40 samples/s, i.e., an order of magnitude faster than current MS platforms. LAP-MALDI requires only low amounts of sample volume (<2 μL), of which only a fraction (<1%) is typically consumed, and allows for multiplexing and high-speed MS/MS analysis, demonstrated at ∼10 samples/s. Its high ion signal stability and similarity to electrospray ionization enables CVs below 10% and the analysis of multiply charged peptide ions at these extreme speeds. LAP-MALDI MS fulfills the speed requirements for large-scale population diagnostics and compound screening with the potential of analyzing >1 million samples per day.

Indexed as

Atmospheric PressureTandem Mass SpectrometryIonsLasersPeptidesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationIonsPeptides

Identifiers

PMID35234449
PMCPMC9385107
OpenAlexW4214867996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.